Observational Study of Patients With Castration-Resistant Prostate Cancer

What we are studying

The purpose of this study is to describe patterns of care and disease assessment method, as well as to identify factors influencing physician treatment decisions and settings, referral patterns and CRPC patient characteristics associated with these. This study will also describe factors influencing treatment decisions including reason(s) for treatment choices and triggers for treatment changes for CRPC as well as describe clinical outcomes based on patient characteristics.

Who we are studying

  • Men
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Patient Inclusion:
    • Confirmed diagnosis of Castration Restistant Prostate Cancer
  • Initiating the first active course of anti-cancer treatment for castrate resistant prostate cancer
  • Patients may be enrolled within 45 days from the time of treatment initiation
  • Willing and able to complete periodic patient-reported outcome (PRO) questionnaires
  • With or without assistance
  • Estimated life expectancy of ? 6 months
  • Caregiver Inclusion:
    • Meets the definition of an unpaid relative or friend who helps the patient with his or her activities of daily living and is willing and able to complete caregiver-reported outcome questionnaires over the course of the patient's participation in the study

What is involved

  • Questionnaires


Gift Card Compensation for completion of questionnaires

Contact Information

Study Coordinator
Patricia Smith, RN

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.